By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French biotech firm IntegraGen today announced that its first-half revenues increased 67 percent year over year driven by demand for its genomic services.

For the half-year, revenues rose to €2.5 million ($3.4 million) from €1.5 million a year ago, resulting in a 32 percent improvement in its net loss to €890,000, compared to €1.3 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.